WeVote

Bill

Bill

A 4538

Requires health care professionals to prescribe opioid antagonists when prescribing an opioid

2025 Regular Session Introduced by Charles Fall

Bill A 4538 mandates health care professionals to prescribe opioid antagonists with opioid medications, enhancing patient safety and reducing overdose risks.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 4538

Summary of Bill A 4538

Bill Number: A 4538
Title: Requires health care professionals to prescribe opioid antagonists when prescribing an opioid
Status: Referred to Health
Introduced: February 04, 2025
Classification: Bill

Purpose and Intent

Bill A 4538 aims to address the growing opioid crisis by mandating that health care professionals prescribe opioid antagonists, such as naloxone, whenever they prescribe opioid medications. The intent of this legislation is to reduce the risk of opioid overdoses and enhance the safety of patients who are prescribed these potentially addictive substances.

Key Provisions

  • Mandatory Prescription of Antagonists: Health care professionals, including physicians and nurse practitioners, will be required to prescribe an opioid antagonist alongside any opioid prescription.

  • Education and Awareness: The bill may include provisions for educating both health care providers and patients about the use of opioid antagonists, their effectiveness in reversing overdoses, and the importance of having them readily available.

  • Exceptions: The bill may outline specific circumstances under which a health care professional may be exempt from this requirement, although these details are not specified in the current version.

Affected Parties

  • Health Care Professionals: Physicians, nurse practitioners, and other prescribers will be directly impacted by the new requirement to prescribe opioid antagonists.

  • Patients: Individuals receiving opioid prescriptions will benefit from the increased safety measures, as they will have access to opioid antagonists that can potentially save lives in the event of an overdose.

  • Pharmacies: Pharmacies may see an increase in the demand for opioid antagonists, requiring them to stock these medications and possibly provide additional counseling to patients.

Procedural Aspects

  • Current Status: The bill was introduced on February 04, 2025, and has been referred to the Health Committee for further consideration.

  • Related Legislation: This bill is related to several prior-session bills, including:

    • A 10619
    • A 2567
    • A 2043
    • S 7508 (companion bill)

These related bills may provide context or additional measures aimed at combating the opioid crisis.

Conclusion

Bill A 4538 represents a proactive step towards mitigating the risks associated with opioid prescriptions by ensuring that patients have access to life-saving opioid antagonists. As the bill progresses through the legislative process, it will be important to monitor any amendments or additional provisions that may be introduced.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.